1. bookVolume 65 (2019): Edition 2 (June 2019)
Détails du magazine
License
Format
Magazine
eISSN
2449-8343
Première parution
04 Apr 2014
Périodicité
4 fois par an
Langues
Anglais
Accès libre

The role of folate receptor and reduced folate carrier polymorphisms in osteoporosis development

Publié en ligne: 30 Jun 2019
Volume & Edition: Volume 65 (2019) - Edition 2 (June 2019)
Pages: 30 - 36
Reçu: 10 Apr 2019
Accepté: 22 Jun 2019
Détails du magazine
License
Format
Magazine
eISSN
2449-8343
Première parution
04 Apr 2014
Périodicité
4 fois par an
Langues
Anglais

1. Akpolat V, Bilgin HM, Celik MY, Erdemoglu M, Isik B. An evaluation of nitric oxide, folate, homocysteine levels and lipid peroxidation in post-menopausal osteoporosis. Adv Clin Exp Med 2013; 22(3):403-409.Search in Google Scholar

2. Tyagi N, Kandel M, Munjal C, Qipshidze N, Vacek JC, Pushpakumar SB, et al. Homocysteine mediated decrease in bone blood flow and remodeling: role of folic acid. J Orthop Res 2011; 29(10):1511-1516.2146917910.1002/jor.21415358330421469179Search in Google Scholar

3. Alley RA, Chen EL, Beyer TD, Prinz RA. Does homocysteine contribute to bone disease in hyper-parathyroidism? Am J Surg 2008; 195:374-377.Search in Google Scholar

4. Herrmann M, Taban-Shomal O, Muller S, Gunter L, Hübner U, Böhm M, et al. Hyperhomocysteinemia – the biochemical link between a weak heart and brittle bones? Clin Lab 2006; 52:137-147.16584060Search in Google Scholar

5. LeBoff MS, Narweker R, LaCroix A, Wu L, Jackson R, Lee J, et al. Homocysteine levels and risk of hip fracture in postmenopausal women. J Clin Endocrinol Metab 2009; 94:1207-1213. doi: http://dx.doi.org/10.1210/jc.2008-177710.1210/jc.2008-1777268246319174498Ouvrir le DOISearch in Google Scholar

6. Albert CM, Cook NR, Gaziano JM, Zaharris E, MacFadyen J, Danielson E, et al. Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: a randomized trial. JAMA. 2008; 299(17):2027-2036. doi: http://dx.doi.org/10.1001/jama.299.17.202710.1001/jama.299.17.2027268462318460663Ouvrir le DOISearch in Google Scholar

7. Bostom AG, Selhub J, Jacques PF, Rosenberg IH. Power Shortage: clinical trials testing the ‘homo-cysteine hypothesis’ against a background of folic acid-fortified cereal grain flour. Ann Intern Med 2001; 135(2):133-137.10.7326/0003-4819-135-2-200107170-0001411453713Search in Google Scholar

8. Yang J, Hu X, Zhang Q, Cao H, Wang J, Liu B. Homocysteine level and risk of fracture: a meta-analysis and systematic review. Bone 2012; 51(3):376-382. doi: http://dx.doi.org/10.1016/j.bone.2012.05.02410.1016/j.bone.2012.05.02422749888Search in Google Scholar

9. van Meurs JB, Dhonukshe-Rutten RA, Pluijm SM, van der Klift M, de Jonge R, Lindemans J, et al. Homocysteine levels and the risk of osteoporotic fracture. N Engl J Med 2004; 350(20):2033-2041. doi: http://dx.doi.org/10.1056/NEJMoa03254610.1056/NEJMoa03254615141041Ouvrir le DOISearch in Google Scholar

10. Kuroda T, Tanaka S, Saito M, Shiraki Y, Shiraki M. Plasma level of homocysteine associated with severe vertebral fracture in postmenopausal women. Calcif Tissue Int 2013; 93(3):269-275. doi: http://dx.doi.org/10.1007/s00223-013-9754-210.1007/s00223-013-9754-223793599Search in Google Scholar

11. Nilsson K, Gustafson L, Isaksson A, Hultberg B. Plasma homocysteine and markers of bone metabolism in psychogeriatric patients. Scand J Clin Lab Invest 2005; 65(8):671-680. doi: http://dx.doi.org/10.1080/0036551050034815310.1080/0036551050034815316319041Search in Google Scholar

12. Gerdhem P, Ivaska KK, Isaksson A, Pettersson K, Vaananen HK, Obrant KJ, et al. Associations between homocysteine, bone turnover, BMD, mortality, and fracture risk in elderly women. J Bone Miner Res 2007; 22(1):127–34. doi: http://dx.doi.org/10.1359/jbmr.06100310.1359/jbmr.06100317032146Ouvrir le DOISearch in Google Scholar

13. Bailey RL, Looker AC, Lu Z, Fan R, Eicher-Miller HA, Fakhouri TH, et al. B-vitamin status and bone mineral density and risk of lumbar osteoporosis in older females in the United States. Am J Clin Nutr 2015; 102(3):687-694. doi: http://dx.doi.org/10.3945/ajcn.115.10878710.3945/ajcn.115.108787454817426224297Ouvrir le DOISearch in Google Scholar

14. Golbahar J, Hamidi A, Aminzadeh MA, Omrani GR. Association of plasma folate, plasma total homocysteine, but not methylenetetrahydrofolate reductase C667T polymorphism, with bone mineral density in postmenopausal Iranian women: a cross-sectional study. Bone 2004; 35(3):760-5.10.1016/j.bone.2004.04.01815336613Search in Google Scholar

15. Gjesdal CG, Vollset SE, Ueland PM, Refsum H, Meyer HE, Tell GS. Plasma homocysteine, folate, and vitamin B 12 and the risk of hip fracture: the hordaland homocysteine study. J Bone Miner Res 2007; 22(5):747-756.10.1359/jbmr.07021017295607Ouvrir le DOISearch in Google Scholar

16. Shiraki M, Urano T, Kuroda T, Saito M, Tanaka S, Miyao-Koshizuka M, et al. The synergistic effect of bone mineral density and methylenetetrahydrofolate reductase (MTHFR) polymorphism (C677T) on fractures. J Bone Miner Metab 2008; 26(6):595-602.10.1007/s00774-008-0878-918979159Search in Google Scholar

17. Abrahamsen B, Madsen JS, Tofteng CL, Stilgren L, Bladbjerg EM, Kristensen SR, et al. A common methylenetetrahydrofolate reductase (C677T) polymorphism is associated with low bone mineral density and increased fracture incidence after menopause: longitudinal data from the Danish osteoporosis prevention study. J Bone Miner Res 2003; 18(4):723-729.10.1359/jbmr.2003.18.4.72312674333Search in Google Scholar

18. Urano T, Shiraki M, Saito M, Sasaki N, Ouchi Y, Inoue S. Polymorphism of SLC25A32, the folate transporter gene, is associated with plasma folate levels and bone fractures in Japanese postmenopausal women. Geriatr Gerontol Int 2014; 14(4):942-946. doi: http://dx.doi.org/10.1111/ggi.1220110.1111/ggi.1220124354357Ouvrir le DOISearch in Google Scholar

Articles recommandés par Trend MD

Planifiez votre conférence à distance avec Sciendo